<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="sars-cov-2 infection sars-cov-2 pathogenesis sars-cov-2 induced ards sars-cov-2 treatment remdesivir" exact="dexamethasone" post="The content published in Cureus is the result of"/>
 <result pre="intubationÂ [24]. Corticosteroids (Dexamethasone) Current guidelines recommend the use of" exact="dexamethasone" post="(6 mg/day for 10 days) in patients with SARS-CoV-2"/>
 <result pre="randomized control trials have shown that the early introduction of" exact="dexamethasone" post="or methylprednisolone to patients with moderate-to-severe ARDS can reduce"/>
 <result pre="trials have shown that the early introduction of dexamethasone or" exact="methylprednisolone" post="to patients with moderate-to-severe ARDS can reduce both mechanical"/>
 <result pre="study on 213 patients demonstrated that the early use of" exact="methylprednisolone" post="(0.5-1 mg/kg/day for three days) resulted in a reduction"/>
 <result pre="of critically-ill patients from China revealed that patients treated with" exact="methylprednisolone" post="(median dosage of 40 mg/day for eight days) were"/>
 <result pre="treated with standard of care (SOC) plus 6 mg/day of" exact="dexamethasone" post="for 10 days to SOC alone. Preliminary analysis of"/>
 <result pre="SOC alone. Preliminary analysis of 6,425 patients (2,104 from the" exact="dexamethasone" post="arm and 4,321 from the control arm) revealed statistically"/>
 <result pre="as the basis for the NIHâ€™s recommendation for the use" exact="dexamethasone" post="in SARS-CoV-2 patients who require ventilator or supplementary oxygen"/>
 <result pre="the treatment arm, is warrantedÂ [37]. In the event that" exact="dexamethasone" post="is unavailable, it is reasonable to use alternative glucocorticoids,"/>
 <result pre="hydrocortisone. The total daily dose equivalencies to 6 mg/day of" exact="dexamethasone" post="for these medications are 40 mg, 32 mg, and"/>
 <result pre="trial by Gilead Sciences. June 1, 2020). Chloroquine, Hydroxychloroquine, and" exact="Azithromycin" post="Current guidelines recommend against the use of high-dose chloroquine"/>
 <result pre="and Azithromycin Current guidelines recommend against the use of high-dose" exact="chloroquine" post="(600 mg BID for 10 days) or hydroxychloroquine plus"/>
 <result pre="of high-dose chloroquine (600 mg BID for 10 days) or" exact="hydroxychloroquine" post="plus azithromycin for the treatment of SARS-CoV-2Â [24]. Chloroquine"/>
 <result pre="chloroquine (600 mg BID for 10 days) or hydroxychloroquine plus" exact="azithromycin" post="for the treatment of SARS-CoV-2Â [24]. Chloroquine and its"/>
 <result pre="or hydroxychloroquine plus azithromycin for the treatment of SARS-CoV-2Â [24]." exact="Chloroquine" post="and its analog hydroxychloroquine have historically been used to"/>
 <result pre="for the treatment of SARS-CoV-2Â [24]. Chloroquine and its analog" exact="hydroxychloroquine" post="have historically been used to treat malaria and certain"/>
 <result pre="reach sufficient antiviral concentrations along with their concurrent use with" exact="azithromycin" post="(another QTc prolonging agent) has further exacerbated these concerns."/>
 <result pre="exacerbated these concerns. Thus far, the safety and efficacy of" exact="chloroquine" post="and hydroxychloroquine in SARS-CoV-2 have been evaluated through a"/>
 <result pre="concerns. Thus far, the safety and efficacy of chloroquine and" exact="hydroxychloroquine" post="in SARS-CoV-2 have been evaluated through a number of"/>
 <result pre="small clinical trials, case series, and observational studies. Studies on" exact="chloroquine" post="have shown minimal efficacy in the treatment of SARS-CoV-2"/>
 <result pre="(600 mg BID for 10 days)Â [42-43]. Studies looking at" exact="hydroxychloroquine" post="have been inconclusive, with results varying from worse to"/>
 <result pre="varying from worse to better outcomes. One study found that" exact="hydroxychloroquine" post="was more likely to be given to patients who"/>
 <result pre="older, underlying comorbidities) and therefore could not be determined whether" exact="hydroxychloroquine" post="administration resulted in an increased or reduced risk of"/>
 <result pre="While others have shown no treatment benefits among patients receiving" exact="hydroxychloroquine" post="Â± azithromycin compared with patients not receiving hydroxychloroquine or"/>
 <result pre="have shown no treatment benefits among patients receiving hydroxychloroquine Â±" exact="azithromycin" post="compared with patients not receiving hydroxychloroquine or SOC aloneÂ"/>
 <result pre="patients receiving hydroxychloroquine Â± azithromycin compared with patients not receiving" exact="hydroxychloroquine" post="or SOC aloneÂ [45]. Conversely, a potential increased risk"/>
 <result pre="and Drug Administration (FDA) does not approve the use of" exact="hydroxychloroquine" post="and chloroquine for the treatment of SARS-CoV-2Â [24]. Immune-Based"/>
 <result pre="Administration (FDA) does not approve the use of hydroxychloroquine and" exact="chloroquine" post="for the treatment of SARS-CoV-2Â [24]. Immune-Based Therapies On"/>
 <result pre="by health care providers with extensive airway management experience. Both" exact="dexamethasone" post="and remdesivir have demonstrated positive early results in clinical"/>
 <result pre="ahead of print]N Engl J MedHorbyPShen LimWEmbersonJet al.2020 38Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="J MedGoldmanJDLyeDCBHuiDSet al.2020 42Effect of high vs low doses of" exact="chloroquine" post="diphosphate as adjunctive therapy for patients hospitalized with severe"/>
 <result pre="with chloroquineJ Mol Cell BiolHuangMTangTPangPet al.32232512202032236562 44Association of treatment with" exact="hydroxychloroquine" post="or azithromycin with in-hospital mortality in patients with COVID-19"/>
 <result pre="Mol Cell BiolHuangMTangTPangPet al.32232512202032236562 44Association of treatment with hydroxychloroquine or" exact="azithromycin" post="with in-hospital mortality in patients with COVID-19 in New"/>
 <result pre="patients with COVID-19 in New York StateJAMARosenbergESDufortEMUdoTet al.24932502323202032392282 45Outcomes of" exact="hydroxychloroquine" post="usage in United States veterans hospitalized with COVID-19 [Online"/>
</results>
